Filter
1088
Text search:
World
Health
Organization
WHO,
Stop
TB
Featured
118
303
Language
Document type
726
131
119
48
28
15
12
2
2
2
2
1
Countries / Regions
50
40
29
28
26
23
23
23
23
23
23
22
20
19
19
17
16
13
13
13
12
12
12
11
10
8
8
7
7
7
5
5
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
436
92
43
41
20
14
14
Toolboxes
359
129
36
23
20
19
18
17
17
13
13
11
10
9
8
8
6
5
4
3
3
2
1
1
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
La publicación evalúa en forma cuantitativa y cualitativa el costo socioeconómico de la tuberculosis en el Perú con la finalidad de mejorar la comprensión real de gasto social y costo que representa para las personas, familias y Estado peruano. Asimismo, desarrolla bajo el marco del Objetivo 4
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Jin et al. Military Medical Research (2020) 7:4 https://doi.org/10.1186/s40779-020-0233-6
Position Article und Guideline
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Accessed: 08.10.2019
Sector Environmental Guidelines, Full technical Update
